Venus Medtech IPO: Valuation Tempting at the Low-End
Venus MedTech (2500 HK) is a leading transcatheter heart valve medical device company in China. Venus has launched a Hong Kong IPO to raise up to...
525 Views
Venus Medtech (启明医疗) IPO: Valuation Still OK at the High End
Venus Medtech launched book building today to raise up to USD 331 million to list in Hong Kong. The deal attracted five cornerstone investors who...
607 Views
Venus Medtech (启明医疗) Pre-IPO: Thoughts on Valuation
Venus Medtech (Hangzhou) is a dominant player in the heart valve replacement devices market in China. The company started pre-marketing for a USD...
553 Views
Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
698 Views
Venus Medtech IPO Initiation: The Heart of the Business
Venus MedTech Hangzhou Inc (1392140D CH) is a leading transcatheter heart valve medical device company in China. VenusA-Valve, a self-developed...
756 Views